A single-blind, placebo-controlled study of effects of atenolol on transient ischemia in "mixed" angina.

The efficacy of atenolol in preventing episodes of transient ischemia during daily life was evaluated in 10 patients with "mixed" angina who underwent a 4-week, single-blind, double-crossover placebo-controlled trial. On day 6 and 7 of each treatment phase, continuous ambulatory electrocardiographic monitoring was performed for 48 hours. On day 7 an exercise test was also performed. Two-hundred and sixty-four ischemic episodes (79% "silent") were recorded during placebo treatment; 98 were recorded during atenolol treatment (63% decrease, p less than 0.01). In agreement with previous observations, most ischemic episodes observed during placebo (156 or 59%) were not preceded by an increase in heart rate. Surprisingly, the beneficial effects of atenolol were more pronounced for these episodes than for those preceded by an increase in heart rate and apparently caused by an increase in myocardial demand (decreases of 72% and 48%, respectively). Painful and painless episodes were decreased by a similar extent. In all patients, the heart rate recorded at the beginning of ST-segment depression was widely variable and significantly lower with atenolol (64 +/- 14 beats/min) than with placebo (81 +/- 13 beats/min, p less than 0.05). During both placebo and atenolol treatment, the highest incidence of ischemic events was observed between 6 A.M. and 9 P.M., in coincidence with the highest levels of the heart rate resting.(ABSTRACT TRUNCATED AT 250 WORDS)
AuthorsS Chierchia, J J Glazier, S Gerosa
JournalThe American journal of cardiology (Am J Cardiol) Vol. 60 Issue 2 Pg. 36A-40A (Jul 15 1987) ISSN: 0002-9149 [Print] UNITED STATES
PMID3303885 (Publication Type: Clinical Trial, Comparative Study, Controlled Clinical Trial, Journal Article)
Chemical References
  • Atenolol
  • Adult
  • Aged
  • Angina Pectoris (drug therapy)
  • Atenolol (therapeutic use)
  • Clinical Trials as Topic
  • Electrocardiography
  • Exercise Test
  • Female
  • Heart Rate
  • Humans
  • Male
  • Middle Aged
  • Monitoring, Physiologic
  • Time Factors

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!

Choose Username:
Verify Password: